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complement activation which appears later during the dialysis
session.
Renal function and intrarenal hemodynamics in acutely hypoxic
rats. B. Zillig and B. Truniger. Medizinische Klinik, Kantonsspital,
Luzern, Switzerland. On the basis of microsphere distribution stud-
ies, inert gas washout and standard clearance data, the effects of
acute hypoxia on intrarenal hemodynamics and renal excretory
parameters were studied in anesthetized, mechanically ventilated
rats. Moderate hypoxia (ventilation with 15% 02; mean arterial
P02, 59 mm Hg) caused a brisk increase in diuresis and natriuresis
without changing GFR or filtered sodium load. Due to a decrease
in renal vascular resistance (R) from 46.4 to 36.6 mm Hg
ml' min', mean renal blood flow stayed constant during hypoxia
in spite of a significant drop in mean arterial blood pressure.
Hypoxic changes in renal function and vascular resistance were not
accompanied by significant changes in intrarenal distribution of
blood flow (IDBF). In four animals responding to servere hypoxia
(10% 02; mean Po,, 45 mm Hg) with oliguria/anuria and hypoten-
sion, R was the lowest of all groups (28.8mm Hg ml-' min'). From
these studies we conclude: 1) In the anesthetized rat, acute hypoxia
increases diuresis and natriuresis without changing IDBF, 2) Hy-
poxic renal vasodilation persists even in oliguria and anuria. 3) An
increase in tubular sodium rejection and a systemic blood pressure
insufficient to sustain glomerular filtration are the two principal
opposing mechanisms determining renal excretory function in the
anesthetized, acutely hypoxic rat.
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Peptic ulceration in kidney transplantation. J. Ahonen, B. Ekiund.
0. Lindfors, B. Kuhiback, and B.L. Lindstrim. 4th Departments of
Surgery and Medicine, University Central Hospital of Helsinki,
Finland. The purpose of the paper is to discuss the yet unsolved
problem of gastroduodenal ulceration in connection with clinical
renal transplantation. The problem was clearly evident when the
results of our first 500 transplantations were analyzed. Gastric or
duodenal ulceration was diagnosed in 46 patients during the post-
transplantation period (9%). This was often associated with severe
complications; hemorrhage was seen in 25 patients (pts), per-
foration in 7. Twelve pts with bleeding and all with perforation
died. Of the bleeders, 8 were operated upon; in 5, partial gastric
resection was performed, and 3 died. In three cases, vagotomy was
done; one patient died. These results indicate that despite the fact
that all the pts were on antacids, the morbidity and mortality in
peptic ulceration is unacceptably high. The poor results of treat-
ment of gastroduodenal ulcers stress the need of more effective
prophylactic measures in these pts. Pretransplantation gastric sur-
gery cannot solve the problem, as only 50% of the pts exhibited
dyspeptic symptoms before the transplantation.
Neuromuscular changes after a successful renal transplantation.
R.E. Ahonen and B. Kock. Department of Neurology, University of
Helsinki, and IV Department of Medicine, Helsinki University Cen-
tral Hospital, Helsinki, Finland. The aim of this work has been to
study the neuromuscular system after a successful renal trans-
plantation. Neurologic status and electrophysiologic recordings
were performed on 20 patients. Biopsies of the gastrocnemius
muscle were taken from 10 patients. Muscles were examined histo-
logically, histochemically, and by EM. The average duration of
hemodialysis before transplantation was 13.9 months. Clinical
polyneuropathy was found in 65% and autonomic neuropathy in
30% of the patients. Their symptoms were milder than those of the
hemodialysis patients. The MCV of the posterior tibial nerve was
normal, and the SCV of the sural nerve had significantly risen
compared to that of the hemodialysis patients. The EMG was
pathologic only in 40%, normal in 33%, and showed regenerative
pattern in 27% of the cases. Muscle pathology was found in 80%,
and 50% of the changes were mild. Most of the regenerative find-
ings in neuromuscular system appeared rapidly within two months
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after the transplantation. Our results support the view that trans-
plantation is an effective treatment if remarkable recovery from
neuropathy is expected.
Neuromuscular reactions in uremic patients treated with diet ther-
apy and regular hemodialysis program. RE. Ahonen and B. Kock.
Department of Neurology, University of Helsinki, and IV Depart-
ment of Medicine, Helsinki University Central Hospital, Helsinki,
Finland. The reactions of the neuromuscular system and the effects
of treatment in uremia were studied by using clinical examination,
electron physiology, muscle histology, histochemistry, and electron
microscopy. The material consists of 30 patients, 13 of them on
diet therapy and 17 on regular hemodialysis. Clinical poly-
neuropathy was found in 69% and autonomic neuropathy in 31%
of those on diet therapy. The MCV of the posterior tibial nerve was
normal, and the SCV of the sural nerve was significantly lowered.
The EMG was pathologic in 63% of the cases and muscle changes
were found in 50% of the biopsies. Of those on regular hemo-
dialysis, 88% had clinical polyneuropathy and 76% had autonomic
derangement. The MCV was slightly lowered, and the SCV was
significantly lowered. The EMG was pathologic in 60% of the
cases, and extensive pathologic muscle changes were observed in
82% of the muscle biopsies. The results indicate that hemodialysis
affects autonomic nerves and causes extensive muscular changes.
Minimum steroid requirements in renal transplant patients mon-
itored by urinary fibrin degradation products (FDP) andcomplement
(C3). J.L. A nderton, L. Fananapazir, and Maureen Eccleston. Renal
Unit and Department of Medicine, Western General Hospital,
Edinburgh. Scotland, United Kingdom. The purpose of this study
was to define the minimum steroid requirement in patients with
well established renal transplants, monitoring rejection by urinary
FDP and C3 measurements. Urinary FDP and C3 were measured
daily over two years in ten patients who had a renal cadaveric
transplant. Steroid therapy was reduced step-wise over an average
period of fifty weeks to minimum values (range, 5 to 10mg; mean,
7,0 mg of prednisone). Three patients developed rejection when
taking 7.5 mg of prednisone for 10, 21, and 50 weeks, respectively.
In these three patients urinary FDP excretion rose markedly 12, 10,
and 8 weeks, respectively, prior to the diagnosis of rejection and
had fallen to pre-rejection values by the time any significant
changes were observed in renal function. C3 appeared in the urine
of two of the three patients who had graft rejection, heralding the
diagnosis by 14 and 11 days, respectively. The minimal steroid
dosage varied from 0.06 to 0.24 mg of prednisone/kg of body wt
(mean, 0.11), and the three patients who rejected did so on doses of
0.10, 0.13, and 0.16 mg/kg. Doses of prednisone less than 10mg
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per day risk the induction of rejection, depending upon the individ-
ual response of the patient.
Accelerated vascular disease following renal transplantation: Ef-
fects of allograft serum on human arterial smooth muscle cell growth
and low-density lipoprotein metabolism. iD. Bagdade, M. Stewart,
and J.J. Albers, Department of Medicine, University of Washing-
ton, Seattle, Washington, U.S.A. Despite impressive technologic
advances, accelerated cardiovascular disease continues to limit the
long-term survival of both renal dialysis and transplant patients.
To determine whether serum factors in renal allograft recipients
might be atherogenic and contribute to their premature cardiovas-
cular morbidity, human arterial smooth muscle cells (SMC), the
proliferation of which is a key event in atherogensis, were grown in
tissue culture, and the effects of allograft sera on SMC growth and
ability to bind, internalize, and degrade human 121 I-low-density
lipoprotein (LDL) were studied. Serum (10%) frc'm renal allograft
patients caused greater stimulation of SMC growth than serum
from either human controls or steroid-treated bronchitics (P <
0.001, analysis of variance). The lipid-free serum protein fraction
which contained this proliferative effect stimulated SMC growth in
a pattern identical to that observed with whole serum from the
allograft recipients. In addition, allograft sera significantly in-
creased both the binding and uptake and delayed the degradation
of 125 1-LDL from control subjects by SMC (I' < 0.01). Thus,
substances present in allograft serum cause SMC's to proliferate
and accumulate cholesterol-rich lipid from plasma intracellularly.
Since these events characterize all atherosclerotic lesions, these
properties of allograft serum may play a role in accelerating vascu-
lar disease in transplant patients.
In vitro evaluation of polycarbonate membrane for hemodialysis.
A. Bionda, F. Carmassi, C. Donadio, R. Pal/a. C/mica Medica II,
Universith, Pisa, Italy. Polycarbonate membrane (P1) per-
meabilities were tested using a rotating batch c[ialyzer. The new
membranes have shown these properties: thickness, 17 sm; burst
stength, 26 cm Hg; ultrafiltration rate, 3.5 ml/hr/mEq/mm Hg.
The permeability tests where performed with increasing mol wt
substances, comparing the results with those obtained with stand-
ard Cuprophane (Cu):
Mol wt
P1
Pobs cm2
Cu
/sec. JO
P1/Cu
%
Sodium 23 61 47 131
Potassium 39 84 44 192
Urea 60 66 38 174
Creatinine 113 43 46 93
Uric Acid 168 45 7 687
Glucose 198 25 15 170
Bromsulfopht. 838 2 0.2 945
where P1/Cu% is the permeability ratio. The polycarbonate mem-
branes have much higher permeabilities than Cuprophane, chiefly
for substances of mol wt between 168 and 838.
Single-needle continuous flow hemodialysis without a control mod-
ule. S. T. Boen, W.A . G. Haagsma-Schouten, and R.J. Birnie. Sint
Lucas Hospital, Amsterdam, Netherlands. A new double lumen
single needle ("Duo-cath") became available, and we will report
our initial experience in ten patients. The device consists of a 13-
gauge arterial needle, through which a 16-gauge inner needle with a
blunt end (venous needle) is inserted. The two ohannels are sepa-
rated from each other, and both needles are functioning simulta-
neously during dialysis (continuous flow). Single-needle dialysis
without the use of a control module is now possible. Recirculation
tests were performed at blood-flow rates of 200 mI/mm or higher. In
eight patients, less than 10% recirculation was found (range, 1.6 to
8.1) and in two patients, between 15 and 18%. Fistula aneurysm,
which acts as a mixing chamber, was probably the cause of the high
percentage of recirculation in one patient; three tests during three
different dialyses showed the same magnitude of recirculation in
this patient. The outflow pressure was 10 to 15 mm Hg higher
compared to two-needle dialysis. The double lumen needle is some-
what more difficult to insert, and a small amount of blood spatters
and is spilled during replacement of the tapered mandrin by the
venous needle. The spattering of blood may prohibit its use in
HBAg positive patients. We conclude that the Duo-cath is a step
forward for the use of single-needle dialysis. The longer duration of
dialysis compared with two needle dialysis can be calculated from
the recirculation percentage.
Chioramines, an aggravating factor in the anemia of patients on
regular dialysis treatment. J. Botella, J,A. Traver, D. Sanz-Gua-
jardo, M. T. Torres, I. Sanjuan, P. Zabala. Clinica Puerta de Hierro,
Madrid, Spain. In two dialysis centers, with a total of 56 patients, it
was found that the tap water had a concentration of total chlorine,
ranging from 0.5 to 1.1 ppm, with a 50 to 95% of chloramines, (70%
as mono and 30% as dichloramine). Eighty-three percent of the
patients had Heinz bodies. Incubating the red blood cells with the
dialysate caused an increase in metahemoglobin from X 1.45% to
X 5.07%, P < 0.0001, and the ascorbate-cyanide test was positive in
all samples. Treatment was started with 500 mg i.v.of ascorbic
acid, once a week, and the hematocrit increased from X 23.71 to 5:
25.88, P < 0.025. Later an accidental and occasional increase in the
concentration of chlorine to 3.5 ppm caused a sudden drop in the
Hct to 20.73 5:, P < 0.0005. At the present time ascorbic acid is
added to the dialysate (1.7 mg/l00 ml) and only 5.56% of the
patients present Heinz bodies, P < 0.0005. Conclusion. In some
dialysis centers, chloramines may be aggravating, chronically and
acutely, the anemia of their patients. This problem is solved by
adding ascorbic acid to the dialysate.
Failure of renal renin depletion without forced diuresis to protect
rats against mercuric chloride-induced acute renal failure (ARF).
D. de Rougemont, F. Brunner, J. Torhorst, L. Peters-Haefeli, G.
Thief. Base!, Switzerland. Further experiments were designed to
conclusively dissociate the effect of massive diuresis from that of
renal renin depletion in mercuric chloride-induced ARF (6 mg of
HgCI2/kg 13W s.c.). Renal renin depletion was induced in unineph-
rectomized rats by four weekly injections of 150mg of DOCA/kg
BW and substituting 1% NaCl for drinking water for two months;
group A (N= 10) continued on 1% NaCI when injected with HgCl2;
group B (N=8) was thirsted for 24 hr before being injected with
HgCI2, and then received water for drinking. High diuresis without
renal renin depletion was induced in group C (N=9) by contin-
ously infusing 96 mI/day of saline with furosemide, 100 mg/liter,
two days before, during, and after HgCl2 administration.
Results:
Renin
Urine flow
before HgCl2
rn//day
P-urea
at 48 hr
mg/IOU ml
after HgCI2
ng A I/mg
cortex/hr
GroupA 47+6 180±21 14±3
Group B 10 + 1 342 40 29 6
Group C 68 + 5 38 8 763 + 72
Conclusions: Renal renin depletion without increased diuresis does
not protect against mercuric chloride-induced ARF, while forced
diuresis protects despite high renal renin.
Combined report on regular dialysis and transplantation in Europe,
VII, 1976: Part 2. F.P. Brunner, C. Chant/er, R.A. Donckerwolcke,
Hi. Gurland, R. Hathway, C. Jacobs, N.H. Se/wood, A.J. Wing,
St. Thomas Hospital, London. England. Statistical report on
intermittent dialysis and transplantation: more detailed informa-
tion cannot be given, as the computer data will only be available
shortly before the congress.
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Graft survival and blood transfusion. H. Brynger, B. Frisk,
i. Ahlmèn, P.-O. Attman, I. Blohmé, L. Sandberg, and L.-E. Gelin.
Surgical Department I, andBlood Centre, Sahlgren's Hospital, Uni-
versity of Gteborg, Göteborg, Sweden. The purpose of this study
was to investigate the effects of preoperative blood transfusion on
graft survival after kidney transplantation in a single center mate-
rial. 241 patients receiving primary kidney grafts were retro-
spectively studied. Noninformative cases were excluded. 22% of the
patients had been transfused prior to transplantation. In dubious
cases, interviews with the patients were carried out. It was found in
patients receiving kidneys from related living donors sharing one
1-ILA-haplotype with the recipient that the one-year graft survival
(nonimmunologic causes of graft loss excluded) was inferior, 25%
compared to 85% in the transfused group. In recipients of cada-
veric kidneys, the difference was 20% between the two groups. One
group of 16 nontransfused patients from one dialysis unit was
separately studied. The patients were all in a good general condi-
tion at the time of transplantation. 13 of the grafts were lost due to
rejection within one year. It could be concluded that primary
kidney transplantation in patients not transfused prior to oper-
ation has an inferior success rate compared to transfused patients.
Loin pain and renal microvascular disease. R.P. Burden, JR.
Dathan, P. Guyer, A. Maclye,. Southampton University Hospitals,
England. A study has been made of patients with recurrent loin
pain in whom urinary infection and structural abnormalities of the
urinary tract had been excluded, in an attempt to confirm earlier
reports of a syndrome of loin pain with radiologically abnormal
intrarenal vasculature. Attention was paid not only to renal angi-
ography but also to renal histology, including immunofluorescent
and electron microscopic techniques. Nine patients were studied in
a 12-month period. All were female with a mean age of 25 yr.
Symptoms were related to oral contraception in five. Angiographic
abnormalities of the peripheral intrarenal arteries were demon-
strated in all, including increased tortuosity, variations in the width
of the lumen, partial or complete occlusion, and stasis of contrast.
The nephrogram showed loss of the normal distinction between
cortex and medulla and evidence of cortical ischemia. Renal histol-
ogy revealed mild mesangial proliferation and increase in matrix,
variation in the width of the basement membrane, but no evidence
of dense deposits. Arterial abnormalities were confined to one
patient with fibrin in an intraglomerular capillary and five patients
with either C3, IgG, or 1gM in afferent arterioles. This study
confirms previous reports of intrarenal vascular disease associated
with loin pain in young female adults and supports the contention
that an abnormality of the coagulation and/or fibrinolytic system
is partly responsible for the pathogenesis.
Dialysis vs. integrated program ofdialysis and transplantation. A.
Cantaluppi, A. Frontini, R. Licini, A. Taransino G. Mecca, and C.
Ponticelli. Divisioni Nefrologia. Bergano. and Milano, Italy. Since
1972, 110 selected patients, treated by hospital (82 patients) and
home (28 patients) dialysis (D), were listed for transplantation
(Tx). Fifty-eight patients could be transplanted (56 with cadaver
grafts), allowing us to compare, in two homogeneous groups of
patients, the results of a policy of D per se (52 patients; age, 38 9
yr; D age, 35 + 24 months) with the results of a policy of D
integrated with Tx (58 patients; age, 35 + 8 yr; age of treatment, 41
+ 23 months). The integrated program has achieved an actuarial
survival rate of 97% at one year and 92% at five years. Graft
survival was 60% at five years. The D per se has achieved an
actuarial survival rate of 98% at one year and 88% at five years. Of
transplanted patients 89% are fully rehabilitated, compared to 67%
of D pts. (P < 0.05). These results demonstrate that an integrated
program of D and Tx offers a chance of life not different from that
of D alone, and a better rehabilitation.
Intensive plasma exchange (IPE), complement-dependent micro-
cytotoxicity (CDC), and renal transplant rejection. C.J. Cardella,
D.M. C. Sutton, J. Falk, A. Katz, P.R. Uldall, and GA. deVeber.
Toronto Western Hospital, Canada. Uncontrolled rejection is often
associated with antibody-mediated vascular injury. Conventional
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antirejection therapy is frequently ineffective. The apparent effec-
tiveness of IPE in anti-GBM disease suggested the use of IPE in
patients with uncontrolled humoral rejection. The 11 IPE treated
rejection episodes in eight patients, who had received convention-
al immunosuppressive therapy, occurred 8 to 135 days post-
transplantation. Each episode was progressive, unresponsive to
conventional antirejection therapy, and associated with histologic
evidence of humoral rejection. After IPE, the serum creatinine fell
in six, plateaued in two, and continued to rise in three. Three of the
eight grafts were eventually rejected, five of the eight maintained
adequate function two weeks to eight months post-IPE. In order to
define the group who responded to IPE treatment, serum cytotoxic
antibody was monitored by CDC to a panel of cells from unrelated
normals representing H LA-A, -B, and -C specificities. Seven of the
eleven rejection episodes were studied. In four, a negative CDC
became positive prior to the rejection, remained positive during
rejection, and became negative after IPE. The serum creatinine fell
in three of these four CDC positive rejections. In the other three,
the CDC was negative throughout, and the serum creatinine did
not fall after IPE. IPE in the presence of adequate drug-induced
immunosuppression appears to be a useful adjunct to the treat-
ment of severe vascular rejection, particularly those rejections as-
sociated with a positive CDC.
Ionized calcium during hemodialysis. S. Conceicao. N.A. Hoenich,
M.K. Ward, T. White, P. Aljama,J. Dewar, D.N.S. Kerr. Univer-
sity ofNewcastle upon Tyne, England. In spite of the popularity of
high calcium dialysate internationally, most centers in UK con-
tinue to use a dialysate calcium of 1.5 to 1.6 mmoles/liter. We have
studied the changes in serum calcium, ionized Ca, phosphate,
protein, albumin, and PTH during dialysis against this fluid to see
whether it suppresses PTH secretion. Arterial blood samples were
drawn hourly during dialysis. Dialysate was checked hourly and its
constancy confirmed. No PTH was detected in effluent dialysate.
Mean results for the first II patients are shown.
Time Ca Ca P04 PTH Prot. AIb.
Pre-D 1.01 2.43 2.27 1.74 70 42
1 hr 1.06 2.47 1.77 1.27 71 41
2 hr 1.10 2.55 1.52 0.88 72 43
3 hr 1.11 2.57 1.42 1.20 76 45
4hr 1.11 2.57 1.50 1.15 76 45
Shr 1.13 2.53 1.56 1.21 77 46
We conclude that a calcium dialysate of 1.54 mmoles/liter is suf-
ficient to raise ionized calcium during dialysis. Patients so treated
have little elevation of PTH predialysis, and it is further suppressed
during dialysis, The rise in serum phosphate late in dialysis was
unexpected but has been observed by others. Its significance will be
discussed.
Hypothalamic-hypophyseal-gonadal axis in patients undergoing
chronic hemodialysis. C. Dalla Rosa, C. Cascone, F. A ntonucci,
I. Mastrogiacomo, C. Foresta. Nephrology Department, Ospedale
Regionale. Treviso and Institute of Semeiotica Medica of the Univer-
sity Hospital, Padova, Italy. The present study was undertaken to
get a deeper knowledge of the correlations between the hypotha-
lamic-hypophyseal-gonadal axis and the clinical conditions in pa-
tients undergoing chronic intermittent hemodialysis. In blood
samples of 25 males and 30 females, we determined by radio-
immunoassay testosterone, prolactin, FSH, and LH under basal
conditions and after stimulation with hypothalamic-releasing hor-
mone (LH/FSH-RH). LH is slightly above normal, and FSH is
normal. Stimulation test with LH/FSH-RH reveals variable val-
ues; in females, peak is usually late. In males, the mean testoste-
rone levels are lower than in normal controls, but in a wide range.
In three patients with normal testosterone and FSH, sperm count
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is below one million per ml. Eight males have normal testosterone
and increased LH levels. Correlation between testosterone and
impotence is partial. These findings suggest that gonadal in-
sufficiency is usually primitive, but we can also find cases of hypo-
thalamic-hypophyseal insufficiency (very low levels at the
LH/FSH-RH stimulation test). The spermatogenesis is early dam-
aged. In 80% of males, impotence is related to low testosterone
levels, in other patients alternative causes must be considered
(psychical disturbances, the degree of neuropathy). Prolactin is
likely one of the causes of amenorrhoea. Pathologic amenorrhoea
can be differentiated from early menopause.
Treatment of peptic ulcer in renal failure. CC. Doherty,
F. O'Connor, K.D. Buchanan, J.F. Douglas, and Mary G.
McGeown. Renal Unit, Belfast City Hosp, and Department of Medi-
cine, Royal Victoria Hospital Belfast, North Ireland. Peptic ulcera-
tion occurs frequently in patients undergoing regular dialysis, and
prophylactic vagotomy is frequently recommended We have stud-
ied 10 undialyzed uremic patients (CRF), 29 patients on regular
hemodialysis (RD) and 70 renal transplant patients (RT). In-
vestigations included barium meal and/or endoscopy, pentagastrin
test, and fasting plasma gastrin. A very high incidence of ulcer was
found in the RD group, (55%) and 20% of these had GI bleeding.
The incidence of GI bleeding in the RT group was less than 10%.
We found a significant difference (P < 0.05) in basal acid output
between those with CRF (2.1 + 0.58 mmol/hr) and those on RD
(4.6 + 0.83 mmol/hr). RD seems to lead to gastric hypersection
and frequent ulceration. The above data suggest that this may not
continue after transplantation. Cimetidene was given to 7 RD
patients with endoscopically proven DU and gastric acid hyperse-
cretion. Symptomatic relief and significant reduction of acid secre-
tion were demonstrated, and no major side effects occurred. There
appears to be a rational basis for conservative treatment of un-
complicated DU in the dialysis patient, and further evaluation of
the new selective antihistamines is indicated.
Combined report of regular dialysis and transplantation of children
in Europe, 1976. R.A. Donckerwolcke, F.P. Brunner, C. Chant/er,
Hf. Gurland, R. Hashway, C. Jacobs, N.H. Se/wood, A.J.
Wing. St. Thomas' Hospital, London, England. Statistical report in
intermittent dialysis and transplantation: more detailed informa-
tion Cannot be given, as the computer data will only be available
shortly before the congress.
Assessment of a whole blood assay for antibody-dependent cell-
mediated cytotoxicity in kidney patients. E. Dupont. Hôpital Univer-
sitaire Brugmann. Brussels, Belgium. Effector cell (K cell) function
has been proposed as a tool for investigation of itnmunosuppres-
sive therapy and has been assessed in kidney patients with a
method requiring minimal amounts of whole blood. Separation
techniques are avoided leaving cell populations unaffected. Use of
SOul of heparinized whole blood in microtubes followed by plasma
washing and targets (51Cr labelled lymphocytes coated with rabbit
ALS) adding in a constant volume of medium makes unnecessary
corrections for variation of packed red cells volume. Participation
of phagocytic cells is unlikely as cytotoxicity level is not modified
by carbonyl iron powder absorption. Comparison of cytotoxicity
expressed by 50 .tI of whole blood with the activity of isolated
lymphocytes at various effectors/targets ratios shows that in nor-
mal subjects and dialysis patients, the activity of whole blood is
always superior to the results obtained by 10° lymphocytes, while
in transplant patients it is always below the activity of 2.5 10
lymphocytes, reflecting the combined effects of lymphopenia and
depressed cellular function. This assay represents, thus, a more
physiologic test for immunosuppression assessment.
Effects of disodium cromoglycate (DSCG) and antihistaminics
(AH) in acute serum sickness. J. Egida, M. Lbpez-Trascasa,
M. Sanchez respo, M. Garcia-Sanchez, A. Baraf, L. Hernando,
S. Casado. Fundacibn Jiménez DIaz, Madrid, Spain. An increase of
vascular permeability seems necessary for the deposition of im-
mune complexes (IC) in acute serum sickness (ASS). It has been
recently shown that a reduction in circulating basophil count oc-
curs 48 hr before the onset of proteinuria. It has been suggested
that the use of DSCG or AH produces an important improvement
of the nephritis. ASS was induced in rabbits by a single iv. injection
of bovine serum albumin (BSA), labelled with 1251, at a dose of 250
mg/kg 8W. To enhance the incidence of disease, 10mg/kg of BSA
in Freund's complete adjuvant was subcutaneously (s.c.) injected
three days before the large dose of BSA. Levels of '251-BSA, total
leucocyte basophils, and proteinuria were determined daily. Circu-
lating IC were assayed by measuring the amount of '251-BSA
precipitated from the plasma by 50% ammonium suphate at 4°C.
Four schedules of treatment were employed: group A, DSCG at 5
mg/kg/day; group B, DSCG at 50 mg/kg/day; group C, DSCG at
50 g/kg/day and hydroxicine at 30 mg/kg/day; group D, DSCG at
50 mg/kg/day and D-clorofeniramine at 0'30 mg/kg/day. The
DSCG was always administered in five, s.c., and the AH in three.
Twelve rabbits were used as controls. The kidneys were studied by
light microscopy and immunofluorescence and some with electron
microscopy. Only rabbits with similar levels of IC were compared.
All treated animals except group A disclosed a lower number of
glomerulonephritis (GN). Rabbits with GN presented no differ-
ence with controls in intensity of proteinuria and immune deposits
in the glomeruli. Some rabbits, injected again with a large dose of
BSA after interruption of drugs, developed GN. At this time, the
diminution of circulating basophils was significant. In summary,
DSCG and AH protect some rabbits and not at all some others.
Therefore, other drugs capable of inhibiting the basophil degranu-
lation and antagonizing permeability factors, including PAF, are
needed.
Exact regulation of ultrafiltration. iA. Flendrig. W.M. Carpay,
W. T. Dekkers. Caiharinaziekenhuis, Eindhoven, Netherlands. An
apparatus has been constructed to regulate ultrafiltration accurately
during dialysis. The principle of the apparatus is that per time
period exactly the same quantity of bath fluid is put into the kidney
as is taken out. The apparatus consists of two isovolumetric pumps
connected in line. The four compartments of the two pumps have
to change their functions at every pumpstroke. This is accom-
plished by a switch-system. There is a continuously closed dialysate
circuit. The fluid extracted from this closed circuit will be repl-
enished from the blood compartment of the kidney. Ultrafiltration
is regulated by a simple peristaltic pump, which sucks the fluid out
of the closed dialysate circuit. The isovolumetric pumps and the
switch-system are driven by the elevated pressure of the dialysate
(0.5 to 1 Ato). The apparatus can be used in single pass dialysis as
well as in recirculation dialysis. Diafiltration and dialysis according
to the Bergstriim principle can be simply performed. Since August,
1975, more than 3,000 dialyses have been done with this apparatus.
Several types of artificial kidneys are used: R.P.-6, Gambro-Lun-
dia, I-I.F.A.K. Ultrafiltration was always accurate within the mea-
suring limits. Considerable improvement was noticed in the well-
being of the patients. Hypotension, nausea, vomiting, and muscle
cramps were not seen anymore.
Reduction in complications and ultrafiltration intolerance in high
efficiency dialysis. U. Graefe, W.C. Fo/lette, and B.H. Scribner.
Department of Medicine, University of Washington, Seattle, U.S.A.
Poor ultrafiltration tolerance and an increased incidence of symp-
toms are limiting factors in the use of short-time, large surface area
dialysis (LS). In previous studies, we demonstrated that ultrafiltra-
tion tolerance can be improved significantly (around 70%) when
LS is performed using bicarbonate (LS-B) instead of acetate (LS-
A) in the dialysate. Bergstrom suggests that limited ultrafiltration
tolerance is caused by changes in plasma osmolality. To examine
this idea, we repeated our previous studies with LS-A and LS-B
and measured osmolality changes in five patients. The plasma
osmolality decreased by 15 mOsm on LS-B and 9 mOsm on LS-A.
We also tested the influence of LS-A and LS-B on the well-being of
six patients, using the Continuous Performance Test as an objec-
tive quantitation of dialysis-related fatigue before and after
dialysis. The decrease in scores on LS-A was 29%, while on LS-8
the decrease was only 9%, P < 0.004. These results suggest that
osmolality shifts are not a major factor in limiting ultrafiltration
tolerance. Further, LS-B dialysis may reduce the postdialysis mor-
bidity associated with LS-A treatment.
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Effect of aldosterone and dexamethasone on the diluting capacity
of thick ascending limbs (TAL) in experimental adrenal in-
sufficiency. H-U. Guische, G. Beer, W. Niedermayer, and M. Mb-
lyusz. Department of Spec. Nephrology, and Department of Physi-
ology, University of Kiel. Germany. Indirect evidence points to an
impaired diluting capacity ofTAL in adrenal insufficiency. Experi-
ments have been performed on adrenalectomized Wistar rats in
order to determine the effect of mineralocorticoid and of glucocor-
ticoid activity on the time course and the steady state of electrolyte
dilution in the TAL. Pulsed-stopped microperfusion experiments
were performed on functionally isolated loops of Henle, and TAL
ion concentration was monitored with a continuously recording
conductivity probe. Results. The time course of dilution was signif-
icantly delayed after adrenalectomy. Maximal dilution within the
TAL under stationary conditions was 28.5 3.5 mM NaCI in
controls and 54.5 + 6.5 ma NaCl(P <0.001) after adrenalectomy.
Aldosterone (10 ug/l00 g, three days) caused a slight, but not
significant improvement of the transport impairment. Dexametha-
sone (50 zg/ 100 g, three days), however, led to a complete normali-
zation of the diluting capacity (26.6 + 3.5 ma NaCI). It is con-
cluded that the NaCI reabsorption in the TAL is regulated by the
action of glucocorticoid hormones.
Is parenteral or oral substitution of essential amino acids beneficial
in patients on chronic hemodialysis? E. Hecking, H. Kiihler,
H. Mader, R. Zobel. I. Med. Univ. Klinik, Mainz, Federal Republic
of Germany. Improvement of total protein, albumin, transferrin,
and several components of the complement system has been re-
ported to occur following infusion of essential amino acids (ess.
AA) in patients on chronic hemodialysis. Thirteen adult patients
out of the chronic home dialysis program received either IS g/day
ofess. AA orally (five chewing tablets) or placebo preparations for
three months in a double blind study. For another three months,
the medication was crossed over. In addition, seven patients on
chronic clinical dialysis were studied over six months. After a
control period of three months, 17.25 g of ess. AA were infused iv.
during the last 90 mm of dialysis for a period of three months. Oral
and parenteral treatment with ess, AA did not result in significant
changes of protein pattern (total protein, albumin, transferrin,
haptoglobin, vitamin A, retinol binding protein, prealbumin, com-
plement (CH5O), and five complement components). Oral therapy
with ess. AA produced a significant (P < 0.01 to 0,05) increase of
blood urea and uric acid and a decrease of iron. Parenteral therapy
with ess, AA led to a small (P < 0.05) increase of blood urea,
calcium and phosphorus. In conclusion, we cannot generally rec-
ommend the oral or parenteral high dose application of ess, AA in
dialysis patients. By contrast, adverse effects may occur also.
Cuprophan hollow fiber dialyzers. NA. Hoenich, J. Luno,
F. Liano, T. White, D.N.S. Kerr, University of Newcastle upon
Tyne, England. Cuprophan hollow fibers (Enka Glanzstoff) are
used in a number of new disposable dialyzers, those manufactured
by Travenol (CCF), Asahi (KIOl, K102), Cobe (HFI3O), and
Bentley (SD 1) have been studied together with the Cordis CDAK,
which uses cellulose acetate fibers. The dialyzers' small molecular
clearance and ultrafiltration characteristics are shown below, and
indicate that despite their smaller surface area, Cuprophan hollow
fiber dialyzers offer a greater flexibility in ultrafiltration. They are
ethylene oxide sterilized and consequently, easier to handle and
use, compared with the formalin sterilized cellulose acetate hollow
fibers:
Surface
area, m1
Clear
Urea
ance
Creatinine
Ultrafiltration
rate
mi/mm/mm Hg
CF 1.5 149 127 0.066
KIOl 1.1 139 109 0.066
Kl02 1.6 158 129 0.076
HFI3O 1.3 145 — 0.045
SDI 1.3 175 146 0.075
CDAK 1.8 174 145 0.043
High efficiency miniature dialyzers: A comparison. N.A. Hoenich,
J. Luno, T. White, D.N.S. Kerr. University of Newcastle upon Tyne,
England. Small, compact multilayer disposable dialyzers which use
polypropylene mesh in place of the conventional molded plastic
plates have recently been produced and used clinically. Three such
designs, the Travenol CP Standard (0.9 m2), the Cobe PPD (1.3
m2), and the Hemoclear u Nephross (1.4 m2) have been studied,
These designs offer high performance, low internal volume, and a
low blood compartment volume, making them ideal for both adult
and pediatric use. Their performance, however, varies considerably
with the duration of dialysis, and this variation is influenced by the
type of proportionating system used. A very efficient dialysate
deaeration system is required to prevent the collection of air in the
dialysate pathways of these small dialyzers.
No. of
blood
layers
Clea
Urea
rance
Vit. B12 BCV
Ultrafiltration
rate
mI/mm/mm Hg
TravenolCP 150 147 24 67 0.046
CobePPD 65 149 30 90 0.061
Hemoclear 61 159 31 64 0.055
Blood compartment volume at a transmembrane pressure of
100 mm Hg.
Hemofiltration: A useful adjunct to dialysis. P. Ivanovich,
C. Huang, N. Stefanovic, and F. del Greco. Department of Medicine.
Section Nephrology Hypertension, Northwestern Univ-McGaw
Medical Centers. Chicago, USA. Between August 1976 and Febru-
ary 1977, hemofiltration (HF) immediately following hemodialysis(HD) has been used 195 times in 25 maintenance HD patients. In 9
of these patients, HF was performed without HD for relief of
pulmonary edema or severe intravascular volume overload. The
Model 5 Cordis Dow Hollow Fiber Artificial Kidney (CDAK 2.5)
was used in all patients both for HD and for HF. Average ultrafil-
trate removal was 1.6 liter/hr at transmembrane pressures of 600
to 750 mm Hg with a total of 2.8 liters being removed per treat-
ment. Saline was required to treat hypotension during HD in 14
instances, with an average infusion of 240 ml. Rarely was addi-
tional saline required when HF was used after HD. When com-
bined with HD or if used independent of HD, HF resulted in
decreased intravascular volume without significant hypotension
and attendant symptoms. In those patients treated by HF exclu-
sively, weight loss averaged 5.1 kg. Blood pressure monitored at
30-mm intervals in these volume overloaded patients averaged
158/97, 163/97, 149/93, and 150/94, respectively. The biochemical
nature of the ultrafiltrate was similar to plasma except for in-
significant quantities of protein and enzymes. Neither plasma nor
ultrafiltrate contained free hemoglobin. HF alone or in combina-
tion with HD using the CDAK 2.5 is a safe, rapidly effective and
asymptomatic method for controlled fluid removal in maintenance
HD patients.
Combined report on regular dialysis and transplantation in Eu-
rope, VII, 1976: Part 1. C. Jacobs, F.P. Brunner, C. Chantler, R.
Donckerwolcke, Hf. Gurland, R. Hathway, N.H. Selwood, A.J.
Wing. St. Thomas' Hospital, London, England. Statistical report on
intermittent dialysis and transplantation: more detailed informa-
tion cannot be given, as the computer data will only be available
shortly before the congress.
Separation of dialysis and ultrafiltration: Does it really help? E. 0.
Jones, M.K. Ward, NA. Hoenich, D.N.S. Kerr. University of New-
castle upon Tyne, England. At Hamburg, Bergstrom presented
evidence that ultrafiltration without dialysis (UF alone) caused less
hypotension, nausea, headache, and cramps than fluid removal
during dialysis (UF&D). We tested this claim as follows: a) Ten
paired studies of UF alone vs. UF&D for rapid fluid removal (10 to
21 ml/min) from patients on RDT. All on UF&D had hypotension
or/and nausea and vomiting, requiring IV saline. Osmolality fell
10 to 20 mOsm/kg. No patient on UF alone experienced these
symptoms or required saline. b) Thirty unpairedstudies of UFalone
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in RDT patients with acute (12) or chronic (18)fluid overload. LVF
was dramatically relieved. No patients had hypotension, nausea,
headache. c) Cross-over study of UF alone (1 hr) plus dialysis (3 hr)
vs. UF&D (4 hr) using Rhodial 75 and RP6. Results to date show
less symptoms when UF is separated from dialysis. Conctusions.
We support the claims of Bergstrom for UF alone. We have used a
wide range of dialyzers to produce UF without technical diffi-
culties. The technique has been used successfully in nonuremic
patients with heart failure.
Serum antibodies (AB) before and after immunization in hemodia-
lized children. C. Kleinknecht, A. Margolis, C. Bonnissol, M. Gaiffe,
S. Sayoun. M. Broyer. Hpital des Enfants-Malades, Paris, France.
To study humoral immunity in non-immunized dialyzed children,
serum AB was measured before and after vaccination. I) Be-
fore vaccination. No detectable AB's were found against measles,
pertussis, poliomyelitis and diphtheria in respectively 22/52, 17/50,
30/50, and 23/24 children studied. By contrast 39/46 children had
protective antitetanic AB titers; of the 21 children who had never
been immunized, 13 had AB titers between 0.1 and 0.15 z/ml.
Despite the absence of antidiphtheric AB, the Schick test was nega-
tive in all children. ii) After vaccination. I) Following adsorbed
vaccines against diphtheria, tetanus and pertussis, seroconversion
was obtained in respectively 16/17, 21/21, and 18/18 patients.
Inactivated poliomyelitis vaccine administered to II children led to
seroconversion for viruses 1, II and III in 70%, 100%, and 64% of
cases. Using live attenuated vaccine in 30 childrensseroconversion
occurred in only 31%, 64%, and 31% of cases for the three viruses.
Measles vaccine was ineffective in 11/12 patients. Conclusion: Hu-
moral immunity is normal in dialyzed patients since adsorbed
vaccines resulted in a normal AB increase. Three abnormal find-
ings were possibly due to uremia: 1) the negative Schick test
indicative of suppressed nonspecific skin reactivity; 2) the inhibi-
tion of tetanus toxin by uremic sera; 3) decreased response to live
vaccines contrasting with a normal response to inactivated vac-
cines and toxoids.
Successful hemodialysis and renal transplantation in a patient with
hemophilia A. RAP. Koene. P.G.G. Gerlag, J.L.J. Jansen, V.A.J.
Kunst. P.G.A.B. Wijdeveld. Department of Medicine, Division of
Nephrology, University of N(/megen. The Netherlands. A 19 year
old male with severe hemophilia A (factor VIII activity, less than
1%) developed terminal renal insufficiency and was subsequently
dialyzed via an external arteriovenous cannula during one year. To
prevent bleeding he received cryoprecipitates from eight donors,
three times a week during dialysis. After one year of uneventful
dialysis, he received a kidney graft from a cadaver donor that was
matched for the B locus antigens. During the first two weeks after
transplantation, his factor VIII level was kept above 70% by daily
cryoprecipitate infusions. Thereafter, he was free from bleeding at
a level of 20% with cryoprecipitates from eight donors, three times
a week. He was discharged from the hospital five weeks after
transplantation with excellent renal function (ECC, 75 mI/mm).
No rejection crisis occurred. His factor VIII requirements re-
mained unchanged after transplantation, indicating that the hu-
man kidney does not substantially contribute to factor VIII pro-
duction.
Interrelationship between blood pressure, kidney function, renin-
aldosterone system, and body sodium content in kidney transplant
artery stenosis (KTAS). H.J. Kornerup, E.B. Pedersen, and 0.
Fjeldborg. Department of Medicine C, A rhus Kommunehospital and
Arhus University, Arhus, Denmark. Plasma renin concentration
(PRC) and plasma aldosterone concentrations (PAC) were exam-
ined in nine hypertensive recipients with KTAS and in eight nor-
motensive recipients comprising the controls. In addition, blood
pressure, kidney function, PRC, PAC, and exchangeable sodium
(Na5) were studied before and after surgical correction of KTAS in
five recipients. PRC was normal and responded normally to oral
sodium-restriction and -loading in six of nine recipients with
KTAS. In the remaining three PRC was varyingly increased on
liberal sodium intake, but suppressed to normal range by sodium-
loading. PAC did not differ from the controls. The effect of surgi-
cal correction of KTAS was uniformly an increase in GFR and
RPF, associated by a decrease in NaE and blood pressure. Pre-
operative values were normal in all. The results indicate that so-
dium retention, which may counterbalance an increased activity
of the renin system, is involved in the pathogenesis of hypertension
due to KTAS. Hence, preoperative determinations of PRC are
difficult to evaluate with regard to predicting the effect of surgical
correction of KTAS on hypertension.
Changes of plasma concentrations and elimination of various hor-
mones by hemofiltration. P. Kramer, D. Matthaei. R. Arnold, P.
Ebert, Ch. Mcintosh, P. Schauder, G. Sch wino, F. Scheler. Univer-
sity Hospital, Department of Internal Medicine, Humboldiallee 1, D
3400 Gintingen, West Germany. Since hemofiltration (RP-6, Rhône
Poulenc) causes a considerable loss of polypeptides with a mol wt
up to 20,000 daltons, hormone deficiency might be an undesirable
side-effect of this new method. Therefore, the elimination rate and
changes of the plasma concentration of various hormones (testos-
terone, cortisone, gastrin, GIP, somatomedin B, insulin, glucagon,
HGH, TSH), ranging in their mol wt from 288 to 28,000 daltons,
were investigated in five patients on intermittent hemofIltration.
HGH, TSH, and cortisone were not eliminated to a significant
extent. A considerable total elimination was observed for testoste-
rone (2.6 to 4.6 sg), gastrin (0.5 to 1.1 ig), GIP (14 to 73g) and
somatomedin B (14 to 26 mg). This loss, however, did not affect
the plasma concentrations. Only the high loss of somatomedin B, a
hormone which is necessary for growth development, appears to be
of clinical relevance and might eventually limit the usefulness of
hemofiltration for the treatment of uremic children. The high
elimination rate of GIP, a gastrointestinal hormone which has a
potentiating effect on the insulin secretion, may explain the favor-
able effect of hemofiltration treatment on the disturbances of car-
bohydrate and lipid metabolism in uremic patients.
New automatic hemofiltration machine with continuously mon-
itored fluid balance. P. Kramer, D. Matthaei, J. Rieger, E.
Quellhorst, F. Scheler. University Hospital, Department of Internal
Medicine, Division of Nephrology, D 3400 G3ttingen, West Ger-
many. According to preliminary experience, hemofiltration seems
to be the treatment of choice for uremic patients with hyper-
phosphatemia, hypcrlipidemia, intractable hypertension, and un-
disciplined fluid intake. One major problem in hemofiltration has
been so far the high personal demand, especially with regard to the
control of fluid balance. First, experience is presented with a new
hemofiltration device, providing a continuously monitored fluid
balance, which needs only minimal supervision by the dialysis
staff. A special pressure-weight-volume-feedback-system allows
preselection of a constant fluid withdrawal with a total error of less
than 150 ml/6-hr-treatment. The advantage of constant fluid with-
drawal with an automatic device for the administration of sub-
stitution fluid could be demonstrated in 36 hemofiltration treat-
ments with this new machine in an uremic patient who was
switched to hemofiltration two years ago because of "dialysis-
resistent hypertension." The patient's well-being even after a re-
duction of body weight by 3 to 4 liters of fluid during a 6-hr
hemofiltration demonstrates the importance of constant with-
drawal of isotonic fluid. According to our preliminary experience,
this new hemofiltration machine (model, Oelrichs) seems to be a
great progress in the management of water-intake problems as
found in many patients on hemodialysis.
Immunological diagnosis of rejection in human renal allotrans-
planted patients: A prospective study. T. Kristensen, N. Grunnet,
HE. Hansen, 0. Fjeldborg, S. Olsen, and F. Kissmeyer-Neilsen.
University Hospital, A arhus. Denmark. The objective of this study
has been to evaluate the recipient's immunologic reactivity towards
donor lymphocytes in relation to rejection episodes. All recipients
(20) of local necrokidneys during 1976 were immunologically mon-
itored immediately before transplantation and subsequently twice
weekly for donor-specific complement dependent lymphocytotoxic
(CDC) antibodies, antibody dependent cell-mediated cytotoxicity
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(ADCC) and cell-mediated lympholysis (CML). Experiments were
performed until graftectomy or dismissal (approx. 1100 patient
days). Clinical diagnosis of rejection was made independently of
immunologic results. All clinically suspected rejection episodes,
except one, were checked by microscopy. A positive CML-test
accompanied 9 out of 11 rejection episodes; the test was negative
on all other occasions. Positive CDC and ADCC tests exhibited no
evident correlations to rejection episodes; positive ADCC may be
more frequent in clinically uncomplicated phases. Positive CML
did not generally proceed clinical graft rejection. Positive CML
before transplantation was observed in two cases and was followed
by irreversible, accelerated, acute rejections. The immunogenetic
specificity of in vivo-educatedcytotoxic lymphocytes is unclear.
The CML-test may prove a reliable tool in rejection diagnosis and
may yield results comparable to graft-biopsy without inflicting any
risk on the patient.
Evaluation of 433 cases with acute renal failure. L. Lachhein, R.
Kielstein, K. Sauer, P. Reinschke, V. Mfiller, I. Krumhaar, D.
Falkenhagen, R. Schmidt, H. Klinkmann. W.-Pieck-Univer. Ros-
lock, DDR. During the period between 1966 and 1976,433 patients
with acute renal failure underwent hemodialysis. The causes of
acute renal failure were classified in eight groups. Postoperative
conditions (24.9%), epigastric diseases, mainly pancreatitis and
"hepatorenal syndrome" (15.0%), and urological diseases includ-
ing abscess-forming pyelonephritis (14.5%) are the most frequent
causes of acute renal failure, amounting to 54.4% of the patients.
The remaining primary diseases are subdivided into septic-toxic
causes, intravascular hemolysis, intoxication with uremia, and mis-
cellaneous diseases. The overall mortality amounts to 50.3%, rang-
ing from 33 to 63% within the different groups. The patients of the
different groups were analyzed concerning age and sex distribu-
tion. With regard to time, the analysis shows that there is no
essential change in the frequency and mortality of acute renal
failure.
Automatic control of ultrafiltration. NA. Larsen, B. Nielsen,
B. Petersen, B. Funck Jensen. 3rd Medical Department (Neph-
rology), Copenhagen Kommunehospital, Copenhagen, and Automata
A/S, Aarhus, Denmark. A system for automatic control of a vari-
able ultrafiltration rate during hemodialysis has been constructed.
Signals from a modified bed scale (Brook-line) served as input. A
control unit continously recorded deviation of the patient's actual
weight from a pre-programmed weight loss curve. The readings
served as the output signals controlling the dialysate vacuum. A
damping device eliminated the effect of short-term bilateral weight
excursions. Dialysate was supplied at a constant inflow rate and
pressure. A clinical trial of the system in 28 hemodialyses with a
plate dialyzer showed that the total weight loss, and the rate at
which it occurred, were consistent with the programmed course in
11 dialyses. The damping device functioned satisfactorily. In 17
dialyses, the rate of weight loss and the planned weight loss dif-
fered from those programmed. In all of these dialyses, the limited
ultrafiltration capacity of the prototype and the lacking automatic
correction of sudden unidirectional weight were found to be the
cause. These technical problems are easily overcome, and the prin-
ciples are thus ready for application in future dialysis monitoring.
Surgical complications in 500 kidney transplantations. B.L. Lind-
strom, o. Lindfors, B. Ekiund, J. Ahonen, R. Collan, B. KuhibOck,
B. Kock, andJ. V. Brotherus. Kidney Transplantation Unit, Helsinki
University Central Hospital, Helsinki, Finland. The complications
needing surgical attention or surgery in 500 kidney trans-
plantations performed between December 1964, and October,
1976, are reported. Among the early surgical complications from
the graft itself, 21 ruptures caused surgical intervention; 15 grafts
were removed. The incidence of ureteral necrosis was low (N = 8).
Complications due to technical problems during the trans-
plantation procedure were few despite the number of 2 to 3 anasto-
mosed arteries in the series reported. The dominating surgical
complications were gastrointestinal and urological. The mortality
rate in gastroenteral bleeding and eases of perforating gastroduo-
denal ulcera were very high.
A typical late complication needing surgery is hypertension due
to renal artery stenosis and hydronephrosis caused by ureteral
stricture. Interestingly, no cases of lymphocele were observed in
this series.
Effect of albumin on diffusion rates of basic peptides across semi-
permeable membrane. K. Markiewicz, W. Lutz. Institute of Internal
Medicine, Medical Academy, Lbdz, Pland, The difusion rates of
basic peptides with mol wt of 1200 to 1800 daltons, isolated from
uremic serum, across a semipermeable membrane (Nephrophan
Dialysiermembrane) were studied. They were found to have a
markedly slower passage to dialysate than urea and creatinine. The
diffusion rates of basic peptides across the membrane depended on
their mol wt. Considerable improvement of basic peptide diffusion
rate was observed after albumin addition to dialysate. Owing to
peptide fixation on albumin present in dialysate, more advanta-
geous gradients of peptide concentrations were obtained between
dialysate and fluid.
Preservation of cadaveric renal allografts. V.C. Marshall,
H. Ross, D.F, Scott, S. Mclnnes, and R.C. Atkins. Monash and
Melbourne Universities. Melbourne, A ustralia. Renal allografts per-
formed in Melbourne prior to 1972 (150) were preserved by ice-
cooling after an isotonic dextran flush; 200 grafts from 1972 to
1975 were preserved by machine perfusion. Storage times were
increased 4-fold by machine preservation (from 4 to 17 hours),
while acute tubular necrosis (ATN) and one year survival times
were similar in each group. Improved results of ice storage after
flushing with hypertonic solutions have been reported recently. In
our hands, a new hypertonic citrate (HC) flushing solution has
given best results experimentally, with successful preservation after
three days of ice storage. Since early 1975, machine perfusion and
ice storage after HC flush have been compared on matched kidney
pairs from the same donor. In 65 consecutive grafts, warm is-
chemia and total storage times were similar in ice-stored and
machine-perfused kidneys (22 vs. 27 mm, 14 vs. 16 hr); ATN
occurred in 40% and 45% of cases, respectively. In both groups,
storage for 24 hr was compatible with immediate early function;
and one year survivals were also similar. Early results indicate no
advantages of machine preservation in clinical cadaveric trans-
plantation on functional, immunologic, or economic grounds.
Blood access in hemodialysis: Long term results. J.P. Masselot,
P. Bonnaud, C. Ciancioni, f.M. Claude, J. Zingraff J. Crosnier.
Hopital Necker, CE. Rist, C.C. Alma, Paris, France. 349 surgical
procedures for blood access have been performed in 310 hemo-
dialysis patients (pts) during a five-year period (1971 to 1976). In
148 pts (48%), Cimino fistula at the wrist was successful (mean
follow up, 27 months). The other 162 pts needed a secondary blood
access: in 86, anastomosis was made using a proximal artery (one
year success, 61%); seven A-V loops with autogenous saphenous
grafts failed; 69 pts received saphenous allografts using part of
removed varicose veins (one year patency rate, 56%). Infection rate
was low (2%); infection did not require graft removal. No high
output cardiac failure has been observed in this series. Arterial
"steal" syndrome supervened in two cases and was cured by reduc-
tion of anastomosis diameter. The most frequent complication was
vein thickening ("jet lesion") beyond the anastomosis; increasing
venous pressure during dialysis and angiography of the fistula lead
to an early diagnosis. The only treatment is surgical repair. In
conclusion, as a primary blood access, Cimino fistula in a distal site
should always be tried; for secondary access procedures, we prefer
saphenous allografts. Angiography was revealed to be very useful
in "difficult" patients.
Hyperglucagonemia and renal failure. R. Matesanz, S. Casado,
I. Valverde, L. Hernando. Fundacibn Jiménez Diaz, Madrid, Spain.
The role of the kidney in the hyperglucagonemia present in renal
failure was studied. Plasma from hemodialysis patients (HD pts),
normal subjects (N) and dogs, one day after nephrectomy, was
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filtered on Blo-Gel P-30 and assayed with 30K antiserum. A
marked basal hypergiucagonemia was found in Ht) pts (450 74
pg/mi), mean SEM, N = 32, vs N, 244 13, N = 24, P <0.0001).
No correlation was found between predialysis plasma glucagon
immunoreactivity (GIR) and levels of urea, creatinine, potassium,
calcium phosphate, total proteins, uric acid, or hematocrit. There
were not statistical differences in plasma GIR from patients with
and without residual renal function or with or wthout kidneys.
This hyperglucagonemia has been shown to be due lo high levels of
both 3500 and 9000 mol wt GIR fractions. In anephric dogs, the t½
of disappearance during a somatostatin infusion was 1.5 to 2-fold
greater than in intact dogs for the 3500 mol wt fraction or "true
glucagon" and 3-fold for the 9000 mol wt component. Lack of
functioning renal parenchyma clearly results in a rise of plasma
GIR, due to an elevation of 3500 and 9000 mol wt GIR fractions.
In HD pts, however, we found no correlation between GIR levels
and severity of uremia or with measurements of residual renal
function.
Long-term hemodialysis: An enhancing factor for cadaveric graft
survival. M. Mebel, W. Seeger, K. Richter, G. May, W. Dutz.
Urological Clinic Friedrichshain, 2nd Medical Clin. Charite and
Transfusion Inst. Berlin, Germany. The influence of long term
dialysis on graft survival has been investigated in a group of 220
consecutive cadaveric kidney grafts. The correlation of dialysis
duration, graft survival, total average number of transfusions, and
incidence of pretransplant HLA-antibodies in percent of antibody
carriers in each group are demonstrated in the table:
Pre-
Yr Cumulative graft survival,yr transplant HLA-
on Patient trans- anti-
RDT no. 1 2 3 4 5 6 fusion body, %
<I 73 0.68 0.62 0.51 0.40 0.35 0.35 10 25
—2 81 0.58 0.50 0.42 0.40 0.40 0.40 26 43
—3 40 0.70 0.65 0.65 0.58 0.58 0.58 40 65
>3 26 0.70 0.70 0.70 0.70 0.70 0.70 56 77
The results show a positive correlation between dialysis duration
and graft survival, possibly due to the formatior of enhancing
antibodies because of multiple blood transfusions. The role of a
long lasting suburemic state remains to be discussed in this context.
A new (alloplastic) vascular prosthesis for reconstruction of sub-
cutaneous A-V fistulae. K. M2hring, U. Ikinger, H. W. Asbach.
Department of Urology, Surgical Center, Universitt of Heidelberg,
Federal Republic ofGermany. Various alternatives including the
use of auto-, hetero-, and homologous vascular material have been
advocated if primary A-V fistulae fail. Since July, 1976, we have
installed a new teflon prosthetic material (Goretex®) in ten pa-
tients, as a substitute for conventional vascular graft materials. All
ten patients had been subjected to numerous fistula operations (up
to 25) and presented with definite problems concerning vascular
access. Five patients had the teflon prosthesis installed sub-
cutaneously at their upper arm, using the brachial artery end-to-
side and the brachial vein end-to-end. In five patients, the teflon
graft was interposed between the formerly occluded, then desob-
literated, radial artery and a suitable arm vein. All these newly
created A-V fistulae are still functioning well. There have been no
difficulties concerning triweekly double-needle punctures, blood
flow, or bleeding at the puncture sites. A total of 27 dialysis-
months has been covered by this new way of vascular access. In
most cases, this was not only urgently needed but added much to
the ease and comfort of repeated vascular access. The new teflon
prosthesis lends itself for construction of A-V fistulae, since con-
structing loops, bends, etc., and anastomoses are easy, contrary to
our experience with auto-, homo-, or heterologous material.
Comparison of dialysis programs on different molecular pre-
scription: A preliminary study. S. Nakagawa, M. Suenaga, N. Yosh-
iyama, J. Takeuchi, T. Kitaoka. S. Koshikawa, T. Yamada. Tokyo
Medical and Dental University, S/iowa University, Josai Dental
University, Tokyo, Japan. With combination of various dialysis
membrane area, diffusion pool sizes, or use of charcoal, it is now
possible to plan programs in such a manner as we call "molecular
prescription." Four prescriptions for three months in which re-
moval of small molecules (SM) and middle molecules (MM) is
different were compared in their effect on predialysis blood chem-
istry, Hct, EEG, NCV, inhibitory effect of plasma on pyruvate-
kinase, lactic dehydrogenase, G-6-PhD, and cell mortality rate in
rat embryo liver culture.
Contents of four prescriptions:
Removal
m2 )<
hr/week
Diffusion
pooi size
Use of
charcoal
—____________
SM MM
A 8.4 Single-pass, No Good Bad
B 16.8 30 liters Yes Worse Better
C 22.5 Single-pass, No Best Good
D 12.0 10 liters Yes Worst Best
After three months, case of prescription D, in which SM removal
was worst and MM removal was best, showed mostly aggravated
results in every parameters. We conclude that dialysis strategy only
against MM, leaving aside SM, should be regarded as clinically
meaningless. Recent enthusiasm on MM is worth reconsidering.
Integration of transplantation and home dialysis. D. 0. Oliver, P.J.
Morris, J. G. G. Ledingham. Departments of Surgery and Neph-
rology, Oxford, United Kingdoms. For 24 months ending 31st Janu-
ary, 1977, renal transplantation (RT) has beert integrated with
home hemodialysis (HD) for 119 patients aged less than 51 yr.
Seventy-six patients have received 82 grafts, of which 75 were
cadaveric (CD) and 7 were from living donors (LD). Six patients
have received second CD grafts, including two in whom the first
graft was LD. The mode of treatment at RT was home HD, 48
(58.5%); home HD training, 16 (19.5%); hospital HD, 16 (19.5%);
and 2 children (2.5%) received CD grafts just before needing HD.
Actuarial survival of grafts and patients at 3, 6, [2 and 24 months
is calculated for the period of integrated therapy. Fifty-four grafts
are functioning with graft survival of 68.5%, 62.1%, 62.1%, and
60.0%, while patient survival is 96.5%, 94.5%, 94.5% and 94.5%.
There were four deaths in patients with function:ing grafts, but no
deaths in 18 patients returned to HD after failed grafts. In 29
patients on HD who have not received grafts, patient survival is
83.3%, 83.3%, 71.8%, and 71.8%. At the end of the period, 35
patients were on the RT list, 29 (82.9%) treated by home HD, 2
(5.7%) training for home HD, and 4(11.4%) on hospital HD. With
similar patient survival in comparable groups supported by either
RT or mainly home HD in an integrated HD/RT program, there is
no longer an ethical dilemma in the choice of treatment.
Clinical experience with circumferentially reinforced, expanded
polytetrafluoroethylene (E-PTFE) graft as a vascular access for
hemodialysis. K. Ota, R. Ara, K. Takahashi. H. Toma, and
T. Agishi. Kidney Center, Tokyo Women's Medical College. Tokyo,
Japan. Long term hemodialysis necessitates vascular grafts avail-
able to blood access. The E-PTFE graft appears to be superior to
the bovine graft in terms of antithrombogenicity and dimensional
availability. The sole defect found in the graft is its weakness to
tensile strength exerted on transverse direction. A new graft is
spirally reinforced with an E-PTFE tape to provide acceptable
sealability and prevent kinking when used as a loop graft. Animal
experiment using 12 dogs revealed its durable usability as a punc-
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turable vascular graft. Thirty-one grafts (4 to 6 mm, I.D.; 18 to 33
cm in length, 0.8 mm in wall thickness) were implanted in the
upper extremities of 30 patents, 28 for loop graft and 3 for straight
graft. Anastomoses were completed without any difficulty, and
bleeding from the suture line was easily controlled. All grafts have
remained patent and functioned as vascular accesses for as long as
12 months, except one which was occluded by hematoma on the
next day of the operation. Subcutaneous edema was a frequent
complication immediately after the implantation. It gradually di-
minished, however, with a time lapse. Puncture was started one to
three weeks after the operation in all cases with satisfactory punc-
tuability and sealability. No aneurysmal dilatation has been ob-
served in any cases.
An experimental study with phenacetin on kidney. M. Ozüer,
H. Tanbola, E. A kahn. Gülhane Military Medical Academy, Etlik.
Ankara, Turkey. Phenacetin is a drug commonly used as an anal-
gesic. It's toxicity on kidney was investigated on 18 white rats. The
drug was given according to the animal's weight, corresponding to
two and four times higher than the dose therapeutically used in
man. Animals were observed for a duration of six months. An
interesting finding was that in animals with low dosage group, even
in two months, pathologic changes were observed. This group
exhibited edematous glomeruli and capillaries full of red cells in
kidneys. At the end of six months, in low dosage treated animals,
many histopathologic findings were seen. These findings demon-
strated that lesions due to the phenacetin toxicity start not from the
medulla, but rather from the cortex of kidney, and medulla is
affected later. Although the previous investigations of others in-
dicated that chronic phenacetin toxicity on kidneys could be
observable at least in a year, in our study it was evident that the
anatomopathologic changes due to phenacetin toxicity were de-
monstrable even in two months. In summary, this study indicated
that patients who are taking drugs containing phenacetin for a long
time might have periodic kidney functioning tests.
Efficacy of vaccine against hepatitis- B: Epidemiological data.
J. Pengloan, Ph. Maupas, A. Goudeau, P. Coursaget, J. Drucker,
Ph. Bagros. B. Grenier. Laboratory of Virology and Haemodialysis
Unit, Cl-JR. Bretonneau, Tours, France. An inactivated hepatitis B
vaccine was prepared, using HBs antigen from healthy blood do-
nors. The vaccine was administered to 103 people: 30 patients and
73 staff members of two hemodialysis units. An epidemiologic
study was carried out from the last three years in one of these
hemodialysis units. It showed that the risk from year to year was
40% to 60% for new subjects to become HBs Ag positive in the nine
months following their admission in the center. Since the beginning
of the immunization in October, 1975, the nonvaccinated patients
and staff members were infected by HB virus with a chance of
infection not significantly different from that seen in the preceding
years (P = 0.40). Comparison of the infection rate in the vacci-
nated and nonvaccinated patients and ward staff members in the 18
months after vaccination was begun shows that the vaccinated
people had been protected from being infected (P = 0.008). After a
year and a half of usage of the vaccination against hepatitis B, it
seems, according to all the epidemiologic, clinical, and serologic
data, that its safety and efficacy are very satisfactory.
Treatment of severe hypertension in chronic renal insufficiency
(CR1) by hemoflltration. E. Quehihorsl, B. Schuenemann, H. Rieger.
Nephrology Center Niedersachsen. Minden, Germany. 15 patients
(pts) with CR1 were transferred from hemodialysis (HO) to a
regular hemofiltration treatment (HF) because of a drug and
dialysis resistant hypertension. HF was performed three
times/week for five hours each, about 20 liters of body fluid being
exchanged. Blood pressure (BP) was normalized in all pts within
three months. l-Ict levels, plasma protein concentrations, renin
activity, extracellular volume (ECV), total body water and blood
volume were controlled repeatedly. At the start of HF treatment,
BP was directly correlated to ECV. During a second period (6 to 8
weeks after the initiation of HF) BP remained normal, in spite of
an increasing ECV, probably because of an influence on barorecep-
tor function. The withdrawal of large amounts of ECV by HF, in
contrast to HO, did not influence the well-being of pts, perhaps as
a consequence of an unchanged plasma osmolality. A change of the
sodium concentration in the substitution fluid from 144 to 135
mEg/liter in HF induced a decrease of plasma osmolality as in HO
with side reactions, whereas a replacement of lactate by acetate in
the substitution fluid did not alter laboratory parameters and
well-being. Thus, HF may be considered to be a safe and easily
performed method for the treatment of severe hypertension in
CR1.
Variable role of erythropoietin deficiency in the pathogenesis of
dialysis anemia. H. W. Radtke, P.M. Erbes, W. Fassbinder, KM.
Koch. Department of Nephrology, University Hospital, Frankfurt,
Federal Republic of Germany. To evaluate the part of reduced
erythropoietin (Ep) production in the pathogenesis of dialysis
anemia, measurements of erythropoietin serum activity (S Ep) by
means of highly sensitive in vitro bioassay (mouse fetal liver cell
culture) were performed in 85 nonnephrectomized, nontransfused,
chronic hemodialysis patients. In 45 patients (group A), S Ep was
lower than the mean of 120 mU/mI of 30 healthy controls. In 40
patients (group B), S Ep ranged from 120 to 380 mU/mI and was
outside the range of 500 to l000 mU/mi established for 20 non-
renal patients with comparable degree of anemia. Group A showed
a highly significant positive correlation between S Ep and Hct (r =
+0.48, P < 0.001) as did 13 anephric patients investigated for
comparison. In contrast, group B displayed a highly significant
negative correlation between S Ep and Hct (r =
—0.53, P < 0.001).
The results demonstrate the existence of two distinctive groups of
equal size in regular hemodialysis patients: those with an absolute
and those with a relative deficiency of Ep. In the case of the latter,
lack of Ep is only a secondary factor in the pathogenesis of anemia,
whereas uremic toxicity and blood loss appear to play a primary
role.
Hemoglobin-oxygen dissociation curve in patients on regular
hemodialysis. C. Raidis, M. Papadimitriou, P. Metaxas, and
D.J. Valtis. Second Propedeutic Department of Medicine, Aris-
totelian University of Thessaloniki. Greece. The investigation of the
changes of the hemoglobin-oxygen dissociation curve (Hb02) on
severely anemic patients with CRF on ROT needs to be expanded
if some of the postdialytic symptoms (wash-out syndrome, etc.) are
to be explained. Seven patients on regular hemodialysis were stud-
ied in 20 dialyses, and seven normal subjects were used as controls.
Dialysis was performed every three to four days for II hours using
a Kiil dialyzer. The HbO2 dissociation curve and the factors which
influence its position were studied before and after each session.
Hb showed a lower than normal affinity to 02 in the uremic
patients before hemodialysis (P50, in vivo = 33.09 + 0.92 mm Hg;
and P50, 7.4 31.51 + 0.73 mm Hg, P < 0.001), and considered as
a biological counterbalance against tissue anemic anoxia. After
dialysis, Hb02 affinity even not changed in vitro (pH 7.4), increased
significantly under the patient's pH (P50, in vivo = 27.97 0.57
mm Hg, P < 0.001). This probably eliminates the benefits of the
predialysis balance of tissue oxygenation, producing a degree of
hypoxia, and plays a role in the genesis of wash-out syndrome. It is
obvious that the measures should be taken for better oxygenation
of high risk patients with latent heart failure or respiratory distur-
bances during and after the dialysis session.
Monitoring and modulation of recipient immune responsiveness to
prevent rejection in early post-transplant period in kidney graft.
E. Renna, P. Sansonetti, C. Nesci, A. Famulair, and R. Cortesini.
Cattedra di Chirurgia Sperimentale, University of Rome, C.N.R.,
Rome, Italy. In 41 consecutive living and cadaver donor renal
transplant recipients, immunologic monitoring was performed two
to three times a week for the first two post-transplant months.
Monitoring consisted of!) circulating T and B cell levels (E-EAC
Rosette assay), 2) T cell reactivity (PHA-Con A), 3) MLC reac-
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tivity, 4) CML and ADCC reactivity. Rejection was diagnosed by
standard techniques, including radioisotope renal scans and biopsy
in some cases. Immunosuppression consisted of prednisone, imu-
ran, cyclophosphamide, and horse ALG. In 32 rejection episodes
in the first two months, 22 (68%) were associated with a rise in T
cells. Rejection activity also correlated with PITEA mitogenesis
count, augmented of 20 5%. There was no positive correlation
between Con A mitogenesis and rejection. There was also no
correlation between rejection and circulating B cell levels. MLC
reactivity showed correlation with early rejection There was no
significant correlation between a positive ADCC md graft rejec-
tion. Furthermore, a positive ADCC in association with a negative
CML resulted in excellent long graft function. Conclusion. An
excellent correlation of levels of circulating T cells and T cell
reactivity with early in vivo rejection was shown.
Binding of antibiotics by dialysis membranes and its clinical rele-
vance. K. W. Rumpf, J. Rieger, R. Ansorg, B. Do/it, F. Sc/icier.
University Hospital, Department of Internal Medicine, 3400 Gttin-
gen, Federal Republic of Germany. Elimination of commonly used
antibiotics (ampicillin, doxycyclin, gentamicin) through dialysis
membranes was measured during routine hemofiltration treatment
in patients with chronic renal failure and in in vitro experiments.
Ampicillin showed a constant filtrate/plasma (F/P)-concentration
ratio, as would be expected. Gentamicin and doxycyclin, however,
exhibited low F/P ratios which increased lineraly with time. In
vitro experiments showed that this unexpected phenomenon de-
pends on binding of these drugs within the dialysis membranes.
The observation of linearly increasing F/P ratios in the in vivo
studies could be explained by "trapping" of the drugs in the
membranes, followed by an "overflow" caused by increasing satu-
ration of the binding capacity of the membranes. The binding of
antibiotics to dialysis membranes is shown to be of clinical rele-
vance, since it could be demonstrated that different dialysis mem-
branes have a large binding capacity of up to 0.4 mg/cm2 for
gentamicin, for example. It is concluded that the elimination of
drugs during hemofiltration cannot be estimated by filtrate concen-
trations alone: binding of drugs to dialysis membranes has to be
considered and dose schedules have to be adjusted to the consid-
erable loss of some drugs within the membranes.
The importance of HLA-matching on primary cadaveric kidney
transplantation in Gothenburg. L. Sandberg, 1. Blohme, H. Brynger,
A. Lindholm, and L.-E. Gelin. Department of Surgery land Blood
Centre, Sahigren's Hospital, University of Gi5teborg, Sweden. The
purpose of the investigation was to study the influence of the
different serologically defined series of HLA-antig ens on the out-
come of cadaveric kidney transplantation in a single center mate-
rial. 349 consecutive, primary, cadaveric kidney transplantations,
performed between March, 1969, and April, 1976, were studied.
The annual graft survival was unchanged during the period, i.e.
50% at 9 months in spite of the fact that the distri ution of "well-
matched" kidneys was very uneven. It was found that the progno-
sis for comparable match-grates was significantly irriproved during
the period and that foreign antigens belonging to the HLA-B series
reduced graft survival more than foreign antigens in the A and C
series.
Clinical experience with hemodiafiltration. H. Schneider, E. Strei-
cher, H. Hachmann, H. Chmiel, H. V. Mylius. Department of Neph-
rology and Hypertension, Katharinenhospital Stuttgart, West Ger-
many. Six patients were selected because of uncontrollable
hypertension (4) and hyperlipidemia (2) for a hemodiafiltration
program. They were treated two to ten months, three times weekly.
Forty-eight times we used a new capillary aromatic polyamid-
membrane, 300 times the RP6 membrane. Medium diafiltration
volume was 60 mI/mm, resp. 20,98 liters for one treatment. The
diafiltrate was continuously substituted, volume-identically, by a
modified Ringer-Lactat solution. In comparison to conventional
dialyzers, we found higher clearances for larger molecules like uric
acid (67.6 mI/mm), anorg. phosphate (64.4 mI/mm), inulin (60.4
mI/mm). The capillary membrane had a significantly lower clear-
ance for inulin (32.1 mI/mm). The amino acid loss in a single
procedure was 3.22 g (N = 5). We could observe a normalization
of amino acid pattern during a six-month treatment. Middle mole-
cules were obtained in diafiltrate in a larger amount at the start of
the treatment. After six months peak 7 nearly disappeared. In
three of four cases severe hypertension markedly improved. In
both cases, hyperlipidemia with triglyceride levels of about 1160
mg/100 ml and 550 mg/lOO ml, respectively, normalized in a range
of two months. According to our preliminary experience, hemodia-
filtration has an advantage in severe hypertension and hyperlipi-
demia.
Effect of recipient variables on graft survival: A study of the fate of
pairs of cadaver kidneys. N.H. Se! wood. EDTA Registration Com-
mittee and U.K. Transplant, England. Survival data collected by the
EDTA Registration Committee has been linked to donor informa-
tion recorded by U.K. Transplant (N.O.M.D.S.) by forming an
"interface" between the two registries. The joint registry data has
been used to study the fate of 477 pairs of cadaver kidneys grafted
in 1975 and 1976. Kidneys from the same donor share premortem
events and therefore provide controlled material against which to
evaluate the effect of recipient parameters. In this study, graft
survival has been related to: 1) age of recipient at time of grafting,
2) length of dialysis prior to grafting, 3) clinical status of the
recipient at the time of grafting as reflected in the rehabilitation
status. (Detailed results cannot be given since the computer data
will only be available shortly before the congress.)
Computer use in management of dialysis and transplant patients.
S. V. Shah, N. W. Levin, S. Parnell, B. Hughes, Henry Ford Hospi-
tal, Detroit, Michigan. An efficient computerized system has been
developed for a large dialysis and transplant program. The pro-
grams, written in a user- (parameter) oriented language (DATA-
SHARE), are supported by a DATAPOINT 5500 series mini-
computer. The system is flexible, allowing new data definitions to
be added at any time. Input from lab results and 30 input forms are
used to generate seven output reports each for dialysis and trans-
plant patients. Attributes of the system include: I) A physician
often has to rely on his memory for management decisions because
the present medical record is cumbersome, disorganized, and fails
to display pertinent data in a time-oriented sequence. The com-
puter will gather information from several sources (e.g., dialysis
forms, lab results, x-rays) and display it in a unified time-oriented
format. 2) Transfer of patients from one facility to another, each
with different physicians, makes transmission of pertinent informa-
tion essential. Terminals at various locations allow immediate
access to information gathered at other sites. 3) The retrieval and
analysis of data in large hemodialysis and transplant units are
difficult and time-consuming tasks. The system can retrieve data
easily on groups selected on any basis (e.g., age, BP, dialyzer type)
and perform extensive statistical analysis. 4) A data base of attri-
butes of potential diagnostic significance can be accumulated for
later decision analysis. The system has potential for improving
patient care and for clinical investigation, but the cost-benefit ratio
needs to be established.
Efficiency of automated reuse of disposable dialyzers. f.M. Van-
denbroucke, A. Stragier, C. van Ypersele de Strihou. University of
Louvain Medical School, Leuven, Belgium. We have devised an
equipment for the automated reuse of disposable dialyzers (RP6
and GAMBRO MAJOR GM) and have investigated the effect of
reuse on dialyzer efficiency and patient tolerance. RP6 dialyzers are
rinsed and sterilized with sodium hypochlorite, 10%, GM dialyzers
are rinsed with sodium hypochlorite, 10%, and sterilized in forma-
ho, 4%. In vitro dialysances (D) of urea, creatinine, glucose, and in-
uhin were measured in new (N = 6)and in ten-times-reused (N = 21)
RP6 dialyzers. No significant difference was observed. Similar
results were obtained in GM (N = 8) after seven reuses. In vivo D
of urea and creatinine were measured in GM (N = 10) during the
1st and 7th dialysis: no difference was noted. Efficiency of reuse
depends critically on the delay between end of dialysis and rinsing:
when delay exceeded 30 mi D dropped over 30% in GM reused
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seven times (N = 10). Tolerance was excellent: only 1/23 patients
had a transient loin pain. By contrast, two patients on RP6 com-
plained of peribuccal paresthesias only when a new dialyzer was
used but not on subsequent reuse. Incidence of anti-N antibodies
(< 10%) was not higher than in a comparable group of patients
treated without reuse. It is concluded that automated dialyzer
reuse does not decrease dialyzer efficiency and is well tolerated
both clinically and immunologically. The procedure is not time
consuming and results in an important money saving.
Kidney graft rejection episode (RE): Time-relationship, prog-
nostic significance and role in infection (1). P. Vereerstraeten,
P. Kinaert, E. Dupont, J.P. De Coninck. I. Van Geertruyden,
C. Toussaint. l-Thpital Universitaire Brugmann, Brussels, Belgium.
From 1965 to 1976, 622 RE, graded according to Williams, were
documented in 255 (232 cadaveric) transplants (220 recipients).
The risk of RE, per patient-month, decreases from 85% in the 1st
month to 3% after the 1st postoperative (P0) year. Cumulative risk
of irreversible (grade 5) RE is 19% for 1st and 33% for 2nd grafts
during the 1st P0 trimester, but the risk is identical (4%) for both
in the ensuing period. Cumulative risk of reversible (grade 0 to 4)
RE is 96% for 1st and 67% for 2nd grafts in the 1st P0 trimester,
but this difference decreases (31 and 21%) afterwards. Chronic
(grade 3) RE incidence increases after 1St grafts while 2nd grafts do
not demonstrate this time-relationship. Patient and graft survivals
are related to RE grade occurring in the 1st P0 month: three-year
survivals are 75 and 69% for grade 0, 70 and 45% for grade 1, 39
and 31% for grade 2, 42 and 10% for grade 3. The risk of I
decreases from 87% at one month to 7% at one year post-trans-
plant. Calculation of risk for Ito occur within the month following
RE yields the following rates: 0 to 24% for skin mycoses, herpes
zoster, upper respiratory and non-specific intestinal 1; 25 to 49%
for hepatitis, urinary salmonellosis, skin and lung bacterial 1; 50 to
74% for herpes simplex, intestinal salmonellosis, bacteremias, non-
specific urinary I, Pn. Carinii lung I and CNS involvements; 75%
for oral and visceral mycoses.
Iron therapy in hemodialysis patients: Oral or parenteral? R.J.
Winney, ('P. Swainson, A. Parker, f.M. Bone, and J.S. Robson.
Medical Renal Unit, University Department of Medicine and De-
partment of Haematology, Royal Infirmary, Edinburgh, Scotland.
There is still controversy regarding the route by which iron supple-
mentation should be given to hemodialysis (IH) patients (pts). 28
pts, established on TH twice weekly, were randomly allocated to
one of two treatment groups: group I) Slow Fe. 320 mg oral daily;
group 2) Imferon, 50 mg iv. once weekly on dialysis. Pts were
assessed before and after 12 months of treatment, but reassessment
was made earlier in some pts if other aspects of treatment were
altered. A significant rise (P < 0.02) in both hemoglobin (Hb) and
hematocrit (Hct) occurred with treatment in both groups and there
was no significant difference between the responses in the two
groups. A rise to normal Hb occurred in two pts in each group.
There was no correlation between serum Fe, TIBC, or marrow iron
stores, and the change in Hb. or Hct. in either group. Over the
period of study, blood transfusion was required in only three pts.
Oral iron iv. iron
Hb Hct Hb Hct
Initial
After
12 mos.
6.8 1.1
8.4 2.5
20.9 3.4 6.1 + 1.4
25.8 + 7,5 7.5 + 2.3
(mean SEM)
18.8 4.8
23.2 + 7.2
This study demonstrates that a significant rise in Hb, occasionally
to normal levels, can be achieved as effectively with oral as with i.v.
iron supplementation.
